These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 10811866)
21. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Khan WN Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380 [TBL] [Abstract][Full Text] [Related]
22. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148 [TBL] [Abstract][Full Text] [Related]
23. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice. Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286 [TBL] [Abstract][Full Text] [Related]
24. Complementary roles for CD19 and Bruton's tyrosine kinase in B lymphocyte signal transduction. Fujimoto M; Poe JC; Satterthwaite AB; Wahl MI; Witte ON; Tedder TF J Immunol; 2002 Jun; 168(11):5465-76. PubMed ID: 12023340 [TBL] [Abstract][Full Text] [Related]
25. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction. Santos-Argumedo L; Lund FE; Heath AW; Solvason N; Wu WW; Grimaldi JC; Parkhouse RM; Howard M Int Immunol; 1995 Feb; 7(2):163-70. PubMed ID: 7734414 [TBL] [Abstract][Full Text] [Related]
26. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase. Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610 [TBL] [Abstract][Full Text] [Related]
27. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells. Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751 [TBL] [Abstract][Full Text] [Related]
28. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822 [TBL] [Abstract][Full Text] [Related]
29. Tracking the response of Xid B cells in vivo: TI-2 antigen induces migration and proliferation but Btk is essential for terminal differentiation. Vinuesa CG; Sunners Y; Pongracz J; Ball J; Toellner KM; Taylor D; MacLennan IC; Cook MC Eur J Immunol; 2001 May; 31(5):1340-50. PubMed ID: 11465091 [TBL] [Abstract][Full Text] [Related]
30. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. Fukuda M; Kojima T; Kabayama H; Mikoshiba K J Biol Chem; 1996 Nov; 271(48):30303-6. PubMed ID: 8939985 [TBL] [Abstract][Full Text] [Related]
31. B-cell antigen receptor activates transcription factors NFAT (nuclear factor of activated T-cells) and NF-kappaB (nuclear factor kappaB) via a mechanism that involves diacylglycerol. Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN Biochem Soc Trans; 2004 Feb; 32(Pt 1):113-5. PubMed ID: 14748726 [TBL] [Abstract][Full Text] [Related]
32. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900 [TBL] [Abstract][Full Text] [Related]
33. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Rawlings DJ; Scharenberg AM; Park H; Wahl MI; Lin S; Kato RM; Fluckiger AC; Witte ON; Kinet JP Science; 1996 Feb; 271(5250):822-5. PubMed ID: 8629002 [TBL] [Abstract][Full Text] [Related]
34. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells. Tomlinson MG; Woods DB; McMahon M; Wahl MI; Witte ON; Kurosaki T; Bolen JB; Johnston JA BMC Immunol; 2001; 2():4. PubMed ID: 11410123 [TBL] [Abstract][Full Text] [Related]
35. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia. Brunner C; Kreth HW; Ochs HD; Schuster V J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599 [TBL] [Abstract][Full Text] [Related]
36. MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses. Alugupalli KR; Akira S; Lien E; Leong JM J Immunol; 2007 Mar; 178(6):3740-9. PubMed ID: 17339472 [TBL] [Abstract][Full Text] [Related]
37. Synergistic B cell activation by CD40 and the B cell antigen receptor: role of B lymphocyte antigen receptor-mediated kinase activation and tumor necrosis factor receptor-associated factor regulation. Haxhinasto SA; Bishop GA J Biol Chem; 2004 Jan; 279(4):2575-82. PubMed ID: 14604983 [TBL] [Abstract][Full Text] [Related]
38. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α. Pontoriero M; Fiume G; Vecchio E; de Laurentiis A; Albano F; Iaccino E; Mimmi S; Pisano A; Agosti V; Giovannone E; Altobelli A; Caiazza C; Mallardo M; Scala G; Quinto I J Mol Med (Berl); 2019 May; 97(5):675-690. PubMed ID: 30887112 [TBL] [Abstract][Full Text] [Related]